Superinvestor Tracker
← All Investors

TALIS BIOMEDICAL CORP

Holders

0

Combined Value

$0

Combined Shares

0

Investor Activity Chart

Quarterly buys (▲) and sells (▼) by tracked investors. Click a marker to view that investor's portfolio; hover for details. Price line is implied from 13F filings (value ÷ shares), not market data.

$0.25$0.70$1.16$1.61Q1'22Q2'22Q3'22Q4'22Q1'23Q2'23Q3'23Q1 2022 · implied price $1.41Q2 2022 · implied price $0.81Q3 2022 · implied price $0.68Q4 2022 · implied price $0.45Q1 2023 · implied price $0.49Q2 2023 · implied price $0.48David Einhorn - Greenlight Capital · bought 2,235,783 shares @ ~$1.41 · Q1 2022 (new position)David Einhorn - Greenlight Capital · sold 2,235,783 shares @ ~$0.48 · Q3 2023 (sold out)BUYSELLIMPLIED PRICE

Held By

Tracked investors currently holding this security, based on each investor's most recent 13F filing. Gain compares the current market price to each investor's estimated average buy price.

InvestorValue% of PortfolioAvg Buy PriceGainLast ActivityAs of

No tracked investors currently hold this security.

Recent Activity

Latest position changes by tracked investors. Prices are estimates implied from 13F filings.

QuarterInvestorActionEst. ValueEst. Price
Q3 2023David Einhorn - Greenlight CapitalSOLD OUT−$1.07M~$0.48
Q1 2022David Einhorn - Greenlight CapitalNEW BUY+$3.15M~$1.41

Ownership History

Aggregate position across all tracked investors per quarter (options excluded). Implied price is the reported value divided by shares held.

PeriodHoldersTotal SharesΔ SharesTotal ValueImplied Price
Q2 202312,235,783UNCH$1.07M$0.48
Q1 202312,235,783UNCH$1.10M$0.49
Q4 202212,235,783UNCH$996.5K$0.45
Q3 202212,235,783UNCH$1.52M$0.68
Q2 202212,235,783UNCH$1.82M$0.81
Q1 202212,235,783—$3.15M$1.41